This inventor holds 1 USPTO granted patent. Top assignee: Oscotec Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations in Bone Grafting: The Contributions of Sung Churl Lee
Introduction
Sung Churl Lee is a notable inventor based in Cheonan, South Korea. He has made significant contributions to the field of biomedical engineering, particularly in the development of bone graft materials. His innovative work focuses on enhancing the effectiveness and safety of bone grafting procedures.
Latest Patents
Sung Churl Lee holds a patent for "Inorganic bone graft materials using animal bone and method for preparing thereof." This invention relates to the preparation of inorganic bone graft materials that meet essential requirements for use in bone grafting. The method involves collecting cancellous bones from animals, removing lipids and organic materials through a series of chemical processes, and sterilizing the bones to ensure biocompatibility and safety. The resulting bone graft materials are designed to be free from immunogenicity and toxicity, making them suitable for osteogenesis and morphogenesis.
Career Highlights
Sung Churl Lee is associated with Oscotec Inc., a company that focuses on innovative solutions in the medical field. His work has contributed to advancements in bone grafting technologies, which are crucial for various surgical procedures. With a patent portfolio that includes 1 patent, he continues to push the boundaries of what is possible in biomedical applications.
Collaborations
Sung Churl Lee has collaborated with notable colleagues, including Jung Keun Kim and Jong Yeo Kim. These partnerships have fostered a collaborative environment that enhances the research and development of innovative medical solutions.
Conclusion
Sung Churl Lee's contributions to the field of bone grafting represent a significant advancement in medical technology. His innovative methods and dedication to improving patient outcomes highlight the importance of research and development in the biomedical sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile